(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 6.04% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Radnet's revenue in 2025 is $1,907,872,000.On average, 4 Wall Street analysts forecast RDNT's revenue for 2025 to be $151,918,606,210, with the lowest RDNT revenue forecast at $151,142,369,312, and the highest RDNT revenue forecast at $152,424,560,065. On average, 3 Wall Street analysts forecast RDNT's revenue for 2026 to be $165,544,901,921, with the lowest RDNT revenue forecast at $163,523,547,812, and the highest RDNT revenue forecast at $167,437,037,047.
In 2027, RDNT is forecast to generate $177,055,390,600 in revenue, with the lowest revenue forecast at $177,055,390,600 and the highest revenue forecast at $177,055,390,600.